First Industry-Sponsored Clinical Trial of a Treatment for Idiopathic Hypersomnia and Narcolepsy without cataplexy

SomnusNooze menu
SomnusNooze menu

NeuroTrials, Inc., has begun recruiting people to take part in the testing of a new treatment for idiopathic hypersomnia and narcolepsy without cataplexy. This small phase 1 study will test the safety and efficacy of a drug that is taken by mouth and swallowed. The study will also determine effective doses of the medication to treat these conditions. The researchers are looking for people who

  • Are 18-65 years old
  • Have idiopathic hypersomnia or narcolepsy without cataplexy
  • Are in general good health with no other sleep disorders

All study-related care and study drug will be provided at no cost. Qualified people may receive compensation. If you are interested in finding out more about this study, please visit the NeuroTrials website or

Share Post

SomnusNooze homepage